Frankfurt am Main, Germany

Klaus Wirth

USPTO Granted Patents = 54 

 

 

Average Co-Inventor Count = 5.5

ph-index = 8

Forward Citations = 275(Granted Patents)


Inventors with similar research interests:


Location History:

  • Kriftel/Taunus, DE (1997)
  • Kriftel, DE (1998 - 2015)
  • Paris, FR (2014 - 2017)
  • Frankfurt-am-Main, DE (1992 - 2018)

Company Filing History:


Years Active: 1992-2018

Loading Chart...
Loading Chart...
Loading Chart...
54 patents (USPTO):

Title: Innovations and Contributions of Klaus Wirth

Introduction

Klaus Wirth is a prominent inventor based in Frankfurt am Main, Germany, holding an impressive portfolio of 54 patents. His work primarily focuses on pharmaceuticals, contributing significantly to the medical field through his innovative inventions.

Latest Patents

Among his latest patents are "Fused pyrroledicarboxamides and their use as pharmaceuticals," which pertains to compounds that are inhibitors of the acid-sensitive potassium channel TASK-1. These compounds are particularly relevant for treating TASK-1 channel-mediated diseases, such as arrhythmias, including atrial fibrillation and sleep-related respiratory disorders like sleep apnea. Another notable patent is for "3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals." This invention involves pharmaceutical active compounds that inhibit the protease cathepsin A, offering potential treatments for prevalent conditions like atherosclerosis, heart failure, renal diseases, liver diseases, and various inflammatory diseases.

Career Highlights

Klaus Wirth has had a significant impact on the pharmaceutical industry, having worked with well-known companies such as Sanofi and Sanofi-Aventis Deutschland GmbH. His experience in these organizations allowed him to apply his innovative thinking and problem-solving skills to complex pharmaceutical challenges.

Collaborations

Throughout his career, Wirth has collaborated with esteemed professionals in the field, including Uwe Heinelt and Hans-Jochen Lang. These partnerships have contributed to the development of his cutting-edge inventions and have bolstered the advancement of pharmaceutical research.

Conclusion

Klaus Wirth's dedication to innovation is evident through his numerous patents and successful collaborations. His contributions to pharmaceuticals not only illustrate his expertise as an inventor but also underline the importance of continuous research and development in addressing health challenges. As the medical field evolves, Wirth's inventions will undoubtedly play a crucial role in improving patient care and treatment outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…